RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share (RAPT)

Historical Holders from Q2 2025 to Q3 2025

Symbol
RAPT on Nasdaq
CUSIP
75382E208
Type / Class
Equity / Common Stock $0.0001 par value per share
Shares outstanding
16.5M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
13.6M
Holdings value
$351M
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
61
Number of buys
33
Number of sells
-24
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share (RAPT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ForGrowth III PA B.V. 7.4% $47.3M 1.83M ForGrowth III PA B.V. Oct 23, 2025
Redmile Group, LLC 9.9% $20.6M 1.77M Redmile Group, LLC Jun 30, 2025
VANGUARD GROUP INC 4.2% $18M 696K The Vanguard Group Sep 30, 2025
Nantahala Capital Management, LLC 3.77% -33% $16.1M -$8.47M 623K -34.5% Nantahala Capital Management, LLC Sep 30, 2025

Institutional Holders of RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share (RAPT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 13.6M $351M +$19.2M $25.79 61
2025 Q2 15.6M $125M +$125M $8.00 45